Etid klinik pou Sipwa nan Davie, FL
6 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Davie (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Encore Medical Research - Weston /ID# 282044, Weston · 11 mi lwen
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- Encore Medical Research of Weston, Weston · 11 mi lwen
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- Encore Medical Research of Weston, Weston · 11 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Encore Medical Research of Weston LLC, Weston · 11 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- Encore Medical Research of Weston LLC, Weston · 11 mi lwen
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Ap rekriteFaz 1
- Encore Medical Research of Weston, Weston · 11 mi lwen
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Davie
- Kansè nan tete7 etid
- Obèsite6 etid
- Ensifizyans kadyak6 etid
- Kansè (tout kalite)5 etid
- Skleroz Amiotrofik Lateral4 etid
- Kansè Poumon ki pa ti selil4 etid
- Dyabèt Tip 24 etid
- Maladi poumon entèstisyèl4 etid
- Ensifizyans renn3 etid
- Blesi ren egi3 etid
- Maladi kadyovaskilè3 etid
- Chòk kadyojèn3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.